-174G/C interleukin-6 gene promoter polymorphism predicts therapeutic response to etanercept in rheumatoid arthritis. [electronic resource]
Producer: 20140113Description: 1481-6 p. digitalISSN:- 1437-160X
- Adult
- Antirheumatic Agents -- therapeutic use
- Arthritis, Rheumatoid -- drug therapy
- Etanercept
- Female
- Genotype
- Humans
- Immunoglobulin G -- therapeutic use
- Interleukin-6 -- genetics
- Male
- Middle Aged
- Polymorphism, Genetic
- Promoter Regions, Genetic
- Receptors, Tumor Necrosis Factor -- therapeutic use
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.